Asia-Pacific Adalimumab Biosimilar Market Analysis 2012-2017 and Forecast 2018-2023

May 2018 | 141 pages | ID: A30A711AE18EN
99Strategy

Abstracts

Snapshot

The Asia-Pacific Adalimumab Biosimilar market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Adalimumab Biosimilar by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Tablet
• Oral Solution

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Adalimumab Biosimilar Industry
  1.1.1 Overview
  1.1.2 Development of Adalimumab Biosimilar
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 AET BioTech (Company Profile, Products & Services, Sales Data etc.)
2.2 Amgen (Company Profile, Products & Services, Sales Data etc.)
2.3 Boehringer Ingelheim (Company Profile, Products & Services, Sales Data etc.)
2.4 Coherus Biosciences (Company Profile, Products & Services, Sales Data etc.)
2.5 Fujifilm Kyowa Kirin Biologics (Company Profile, Products & Services, Sales Data etc.)
2.6 LG Life Sciences/Mochida Pharmaceutical (Company Profile, Products & Services, Sales Data etc.)
2.7 Momenta Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.8 Oncobiologics (Company Profile, Products & Services, Sales Data etc.)
2.9 Pfizer (Company Profile, Products & Services, Sales Data etc.)
2.10 Samsung Bioepsis (Company Profile, Products & Services, Sales Data etc.)
2.11 Sandoz (Company Profile, Products & Services, Sales Data etc.)
2.12 Zydus Cadila (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 ADALIMUMAB BIOSIMILAR MARKET BY TYPE

4.1 By Type
  4.1.1 Tablet
  4.1.2 Oral Solution
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Hospital Pharmacy
  5.1.2 Demand in Retail Pharmacy
  5.1.3 Demand in Online Pharmacy
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION-LIST OF TABLES

Table PRODUCT SEGMENT OF ADALIMUMAB BIOSIMILAR
Table Asia-Pacific Adalimumab Biosimilar Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Adalimumab Biosimilar
Table Asia-Pacific Adalimumab Biosimilar Market 2012-2023, by Application, in USD Million
Table AET BioTech Overview List
Table Adalimumab Biosimilar Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Adalimumab Biosimilar Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Adalimumab Biosimilar Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Coherus Biosciences Overview List
Table Adalimumab Biosimilar Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fujifilm Kyowa Kirin Biologics Overview List
Table Adalimumab Biosimilar Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table LG Life Sciences/Mochida Pharmaceutical Overview List
Table Adalimumab Biosimilar Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Momenta Pharmaceuticals Overview List
Table Adalimumab Biosimilar Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Oncobiologics Overview List
Table Adalimumab Biosimilar Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Adalimumab Biosimilar Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Samsung Bioepsis Overview List
Table Adalimumab Biosimilar Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz Overview List
Table Adalimumab Biosimilar Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zydus Cadila Overview List
Table Adalimumab Biosimilar Business Operation of Zydus Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Adalimumab Biosimilar Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Adalimumab Biosimilar Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Tablet
Table Major Company List of Oral Solution
Table Asia-Pacific Adalimumab Biosimilar Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Market 2012-2017, by Type, in Volume
Table Asia-Pacific Adalimumab Biosimilar Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Market Forecast 2018-2023, by Type, in Volume
Table Adalimumab Biosimilar Demand in Hospital Pharmacy, 2012-2017, in USD Million
Table Adalimumab Biosimilar Demand in Hospital Pharmacy, 2012-2017, in Volume
Table Major Consumers in Hospital Pharmacy
Table Adalimumab Biosimilar Demand in Retail Pharmacy, 2012-2017, in USD Million
Table Adalimumab Biosimilar Demand in Retail Pharmacy, 2012-2017, in Volume
Table Major Consumers in Retail Pharmacy
Table Adalimumab Biosimilar Demand in Online Pharmacy, 2012-2017, in USD Million
Table Adalimumab Biosimilar Demand in Online Pharmacy, 2012-2017, in Volume
Table Major Consumers in Online Pharmacy
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Adalimumab Biosimilar Demand Forecast 2018-2023, by Application, in USD Million
Table Adalimumab Biosimilar Demand Forecast 2018-2023, by Application, in Volume
Table Adalimumab Biosimilar Production 2012-2017, by Region, in USD Million
Table Adalimumab Biosimilar Production 2012-2017, by Region, in Volume
Table Asia-Pacific Adalimumab Biosimilar Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Market Size 2012-2017, by Region, in Volume
Table China Adalimumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table China Adalimumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table China Adalimumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table China Adalimumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Adalimumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Adalimumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table Japan Adalimumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table Japan Adalimumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table Japan Adalimumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table Japan Adalimumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table India Adalimumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table India Adalimumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table India Adalimumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table India Adalimumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table India Adalimumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table India Adalimumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Adalimumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Adalimumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Adalimumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Adalimumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Adalimumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Adalimumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Oceania Adalimumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table Oceania Adalimumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table Oceania Adalimumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table Oceania Adalimumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table Oceania Adalimumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table Oceania Adalimumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Adalimumab Biosimilar Market Forecast 2018-2023, by Region, in USD Million
Table Adalimumab Biosimilar Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Adalimumab Biosimilar

List Of Figures

LIST OF FIGURES

Figure Adalimumab Biosimilar Industry Chain Structure
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth Rate 2012-2023
Figure China Adalimumab Biosimilar Market, by Company, in 2018
Figure Japan & Korea Adalimumab Biosimilar Market, by Company, in 2018
Figure India Adalimumab Biosimilar Market, by Company, in 2018
Figure Southeast Asia Adalimumab Biosimilar Market, by Company, in 2018
Figure Oceania Adalimumab Biosimilar Market, by Company, in 2018
Figure Asia-Pacific Adalimumab Biosimilar Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Adalimumab Biosimilar Market Growth 2012-2017, by Type, in Volume
Figure China Adalimumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure China Adalimumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Adalimumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Adalimumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure India Adalimumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure India Adalimumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Adalimumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Adalimumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Oceania Adalimumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure Oceania Adalimumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview